ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CCCC C4 Therapeutics Inc

6.16
-0.64 (-9.41%)
11 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
C4 Therapeutics Inc CCCC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.64 -9.41% 6.16 13:00:13
개장가 저가 고가 종가 전일 종가
6.85 6.15 6.935 6.16 6.80
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/05/202420:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202420:07EDGAR2Form 8-K - Current report
08/05/202420:00GLOBEC4 Therapeutics Reports First Quarter 2024 Financial Results..
30/04/202405:01GLOBEC4 Therapeutics Announces Inducement Grant Under Nasdaq..
09/04/202420:00GLOBEC4 Therapeutics to Participate in the Stifel 2024 Targeted..
08/04/202421:00GLOBEC4 Therapeutics Presents New Preclinical Data for CFT1946..
09/03/202409:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202409:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202409:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:10EDGAR2Form 8-K - Current report
06/03/202406:30GLOBEC4 Therapeutics to Present New Preclinical Data on Highly..
04/03/202421:05EDGAR2Form 8-K - Current report
04/03/202421:00GLOBEC4 Therapeutics Announces Strategic Discovery Research..
22/02/202423:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/02/202421:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202421:15EDGAR2Form 8-K - Current report
22/02/202421:00GLOBEC4 Therapeutics Reports Fourth Quarter and Full Year 2023..
16/02/202407:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202423:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202400:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/02/202423:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/01/202406:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/01/202421:05EDGAR2Form 8-K - Current report
10/01/202406:06EDGAR2Form 8-K - Current report
10/01/202406:01GLOBEC4 Therapeutics Announces 2024 Priorities and Extended Cash..
05/01/202406:01GLOBEC4 Therapeutics Announces Closing of $25 Million Equity..
04/01/202421:00GLOBEC4 Therapeutics to Present at the 42nd Annual J.P. Morgan..
04/01/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202306:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/12/202306:28EDGAR2Form 8-K - Current report
13/12/202306:01GLOBEC4 Therapeutics Announces Positive Data from CFT7455 Phase 1..
12/12/202323:15APSBiotech Catches Major Premarket Bid
12/12/202321:15EDGAR2Form 8-K - Current report
12/12/202321:00GLOBEC4 Therapeutics Announces License and Research Collaboration..
28/11/202321:00GLOBEC4 Therapeutics to Host Webcast to Present New Dose..
20/11/202321:05EDGAR2Form 8-K - Current report
20/11/202321:00GLOBEC4 Therapeutics Strengthens Board of Directors with Owen..
14/11/202306:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/11/202320:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202320:18EDGAR2Form 8-K - Current report
01/11/202320:00GLOBEC4 Therapeutics Reports Third Quarter 2023 Financial Results..
11/10/202320:00GLOBEC4 Therapeutics Announces Upcoming Data Presentations for..
04/10/202305:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock